Todd C. Brady, Director at Evoke Pharma Inc (EVOK), bought 4,000 shares at $5.70 ($23K) on 2014-09-23, disclosed to the SEC on 2014-09-24.
Open-market purchase of $23k EVOK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |